ABO血型不合引起的新生儿溶血180例溶血三项试验结果分析

Hemolytic Three Test Results Analysis for the 180 Cases of AISO Blood Group Incompatibility Caused Hemolytic Disease of the Newborn

目的：探讨由母婴ABO血型不合引起的新生儿溶血病（HDN）的血型分布及其溶血三项检测试验的重要性,为临床提供ABO HDN 的诊断依据.方法：对2008年3月-2009年1月间在我院出生的母亲血型为O型、疑似为ABO HDN的180例新生儿血样进行溶血三项检测试验.结果：在180例新生儿溶血标本中总阳性率为58.3% （105/180）,其中A型95例阳性率为61%（58/95）,B型85例阳性率为55.3% （47/85）.结论：溶血三项检测试验可为母婴ABO血型不合引起的新生儿溶血病提供可靠诊断依据.

Objective： To investigate the blood type distribution in the ABO blood group incompatibility caused hemolytic disease of newborn and check the efficiency of the hemolytic three test. Methods： 180 cases of patients whom blood type of mother were O and were suspected as ABO blood group incompatibility caused hemolytic disease of newborn were collected from Mar. 08 to Jan. 09 to do hemolytic three test. Results： The positive rate of hemolytic three test was 58.3% in all 180 cases, 61% in 95 cases of blood type A patients, 55.3% in 85 cases of blood type B patients. Conclusion： The hemolytic three tests is a reliable tool for the diagnosis of blood group incompatibility caused hemolytic disease.